These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23143229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
    Kumar-Singh S.
    Int J Mol Sci; 2009 Apr 23; 10(4):1872-1895. PubMed ID: 19468344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O, Bethge T, Marcello A, Harmeier A, Jawhar S, Lucassen PJ, Multhaup G, Brody DL, Esparza T, Ingelsson M, Kalimo H, Lannfelt L, Bayer TA.
    J Neural Transm (Vienna); 2010 Jan 23; 117(1):85-96. PubMed ID: 19823761
    [Abstract] [Full Text] [Related]

  • 7. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
    Kulic L, McAfoose J, Welt T, Tackenberg C, Späni C, Wirth F, Finder V, Konietzko U, Giese M, Eckert A, Noriaki K, Shimizu T, Murakami K, Irie K, Rasool S, Glabe C, Hock C, Nitsch RM.
    Transl Psychiatry; 2012 Nov 13; 2(11):e183. PubMed ID: 23149447
    [Abstract] [Full Text] [Related]

  • 8. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A, Lau HHC, Stuart E, Goczi AN, Wang Z, Schmitt-Ulms G, Watts JC.
    Acta Neuropathol Commun; 2018 Apr 03; 6(1):26. PubMed ID: 29615128
    [Abstract] [Full Text] [Related]

  • 9. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF, Schmidt ML, Nee LE, Bird T, Nochlin D, Hulette C, Mori H, Lee VM, Trojanowski JQ.
    Neurology; 2000 Jan 11; 54(1):100-4. PubMed ID: 10636133
    [Abstract] [Full Text] [Related]

  • 10. N-truncated Aβ4-x peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models.
    Wirths O, Walter S, Kraus I, Klafki HW, Stazi M, Oberstein TJ, Ghiso J, Wiltfang J, Bayer TA, Weggen S.
    Alzheimers Res Ther; 2017 Oct 04; 9(1):80. PubMed ID: 28978359
    [Abstract] [Full Text] [Related]

  • 11. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM, Kang SS, Olley BM, Gatherer M, Shinohara M, Lozano PA, Liu CC, Kurti A, Baker KE, Dickson DW, Yue M, Petrucelli L, Bu G, Carare RO, Fryer JD.
    Proc Natl Acad Sci U S A; 2017 Aug 15; 114(33):E6962-E6971. PubMed ID: 28701379
    [Abstract] [Full Text] [Related]

  • 12. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J, Richard BC, Klafki HW, Friedrich B, Bayer TA, Wiltfang J, Kovacs GG, Ingelsson M, Lannfelt L, Paetau A, Bergquist J, Wirths O.
    Acta Neuropathol Commun; 2016 Mar 08; 4():24. PubMed ID: 26955942
    [Abstract] [Full Text] [Related]

  • 13. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM.
    J Neurosci; 2005 Mar 16; 25(11):2803-10. PubMed ID: 15772340
    [Abstract] [Full Text] [Related]

  • 14. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
    Lloyd GM, Trejo-Lopez JA, Xia Y, McFarland KN, Lincoln SJ, Ertekin-Taner N, Giasson BI, Yachnis AT, Prokop S.
    Acta Neuropathol Commun; 2020 Mar 12; 8(1):31. PubMed ID: 32164763
    [Abstract] [Full Text] [Related]

  • 15. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Méndez E, Jiménez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B.
    Acta Neuropathol; 2000 Jul 12; 100(1):1-12. PubMed ID: 10912914
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A, Yamamoto T, Shimizu K, Ugawa Y, Nishizawa M, Takahashi H, Kakita A.
    J Neuropathol Exp Neurol; 2012 Aug 12; 71(8):750-9. PubMed ID: 22805778
    [Abstract] [Full Text] [Related]

  • 17. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E, Sahlin C, Portelius E, Johannesson M, Söderberg L, Fälting J, Basun H, Möller C, Odergren T, Zetterberg H, Blennow K, Lannfelt L, Brinkmalm G.
    Neurosci Lett; 2021 May 29; 754():135894. PubMed ID: 33848613
    [Abstract] [Full Text] [Related]

  • 18. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H.
    Neurobiol Aging; 2001 May 29; 22(3):367-76. PubMed ID: 11378241
    [Abstract] [Full Text] [Related]

  • 19. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL, Le KX, Cynis H, Ekpo E, Kleinschmidt M, Palmour RM, Ervin FR, Snigdha S, Cotman CW, Saido TC, Vassar RJ, St George-Hyslop P, Ikezu T, Schilling S, Demuth HU, Lemere CA.
    Am J Pathol; 2013 Aug 29; 183(2):369-81. PubMed ID: 23747948
    [Abstract] [Full Text] [Related]

  • 20. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, Kusters B, Maat-Schieman ML, de Waal RM, Verbeek MM.
    Acta Neuropathol; 2006 Feb 29; 111(2):139-49. PubMed ID: 16485107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.